IWMF is excited to share the launch of the WM-Net website — a national collaboration of 24 leading U.S. academic medical centers advancing translational research and innovative clinical trials for Waldenstrom's macroglobulinemia. Explore WM-Net’s mission, participating medical centers, and current studies at WM-Net.org.
WM-Net is the premier clinical trial network dedicated exclusively to advancing innovative therapies for Waldenström’s macroglobulinemia (WM). Comprising 24 leading academic medical centers, WM-Net unites the foremost investigators in the field to accelerate the translation of discovery into patient care.
Click below to visit the WM-NET website
https://www.wm-net.org/